CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-04 | Flynn James E 10% owner | Purchase | +800,000 | $16.00 | $12.8M | 2,552,787 |
| 2021-05-04 | Flynn James E 10% owner | Conversion · Series B Preferred Stock | −15,195,094 | 0 | ||
| 2021-05-04 | Sphera Global Healthcare Management LP 10% owner | Conversion | +312,997 | 312,997 | ||
| 2021-05-04 | Sphera Global Healthcare Management LP 10% owner | Purchase | +475,000 | $16.00 | $7.6M | 787,997 |
| 2021-05-04 | Sphera Global Healthcare Management LP 10% owner | Conversion · Series B Preferred Stock | −2,713,410 | 0 | ||
| 2021-05-04 | Arkin Bio Ventures 2 L.P. 10% owner | Conversion | +1,235,917 | 1,235,917 | ||
| 2021-05-04 | Arkin Bio Ventures 2 L.P. 10% owner | Conversion | +410,717 | 1,646,634 | ||
| 2021-05-04 | Arkin Bio Ventures 2 L.P. 10% owner | Purchase | +400,000 | $16.00 | $6.4M | 2,046,634 |
| 2021-05-04 | Arkin Bio Ventures 2 L.P. 10% owner | Conversion · Series A Preferred Stock | −10,714,284 | 0 | ||
| 2021-05-04 | Arkin Bio Ventures 2 L.P. 10% owner | Conversion · Series B Preferred Stock | −3,560,551 | 0 | ||
| 2021-05-04 | Taiho Ventures LLC 10% owner | Conversion | +1,318,311 | 1,318,311 | ||
| 2021-05-04 | Taiho Ventures LLC 10% owner | Conversion | +438,098 | 1,756,409 | ||
| 2021-05-04 | Taiho Ventures LLC 10% owner | Purchase | +312,500 | $16.00 | $5.0M | 2,068,909 |
| 2021-05-04 | Taiho Ventures LLC 10% owner | Conversion · Series A Preferred Stock | −11,428,570 | 0 | ||
| 2021-05-04 | Taiho Ventures LLC 10% owner | Conversion · Series B Preferred Stock | −3,797,921 | 0 | ||
| 2021-05-04 | Asanuma Sakae Director | Conversion | +1,318,311 | 1,318,311 | ||
| 2021-05-04 | Asanuma Sakae Director | Conversion | +438,098 | 1,756,409 | ||
| 2021-05-04 | Asanuma Sakae Director | Purchase | +312,500 | $16.00 | $5.0M | 2,068,909 |
| 2021-05-04 | Asanuma Sakae Director | Conversion · Series A Preferred Stock | −11,428,570 | 0 | ||
| 2021-05-04 | Asanuma Sakae Director | Conversion · Series B Preferred Stock | −3,797,921 | 0 |
Page 15 of 17 · 335 trades